🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03999138
Recruiting Observational

MRI Assessment of Pulmonary Edema in Acute Heart Failure

NCT03999138 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2019-01-02
Last updated
2026-05-08

Condition(s) studied

Acute Heart FailurePulmonary Edema With Heart Failure

Investigational drug(s) / intervention(s)

MRI

MRI: MRI studies (non-contrast) will consist of a free-breathing localizer (\~10 seconds) followed by a free-breathing yarnball water density scan, for a total MRI time of \< 3 minutes.

Study summary

Researchers are testing a more accurate way to measure how much fluid is in the lungs (also called pulmonary edema, or "increased lung water") in people with Heart Failure (HF) using MRI (Magnetic Resonance Imaging). There is little known about the exact level of lung water in patients with AHF or how these levels change from the time of hospital admission to discharge. The purpose of this research study is to measure the lung water in patients hospitalized for HF, to determine the change in lung water over the course of hospitalization and treatment, and to find out if lung water levels can predict if patients are higher or lower risk for returning to the hospital or dying from heart failure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years of age or older and willing/able to provide informed consent * patients being treated for acute heart failure (including those patients with both reduced and preserved ejection fraction) * patients receiving medical therapy for pulmonary edema by current standard of care (including oral or IV diuretics) * patients identified within 48 hours of initiation of medical therapy for pulmonary edema, defined as the time of first diuretic (IV or PO) or escalation of existing diuretic therapy administered within the ED or hospital Exclusion Criteria: * contraindication to MRI * patient too critically ill/unstable as per the clinical care team for transport to MRI scanner within the required scanning window * moderate to severe dementia

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
University of Alberta Edmonton Alberta Active Not Recruiting
University of Ottawa Heart Institute Ottawa Ontario Recruiting

More University of Alberta trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03999138 on ClinicalTrials.gov ↗ ← All trials in Canada